In 2023, we will work just as hard to keep the engine running at full speed. The past 5 years have shown that the Oncode approach works.  Moving forward, we will keep learning from our experiences, evolve our way of working and accept new challenges.

We continue to invest in curiosity-driven basic cancer research to drive the next breakthroughs in our understanding the disease and to innovate ways to combat cancer. We aim to further expand this by initiating new ambitious Oncode Accelerator Projects. These projects are aimed at addressing big unanswered scientific and medical challenges.

These challenges require the focused attention of large multi-disciplinary teams. Another ingredient which is at the heart of what we do is proactive valorisation: a team of experts supported by dedicated funds, who know how to move a discovery from the lab towards a new therapy or diagnostic tool for patient benefit. We want to make sure all those new insights that researchers bring are further developed towards patients. In the coming years, we aim to offer this expertise to teams beyond Oncode.

Looking ahead, we see another big thing coming our way. A large consortium of public and private partners has joined forces to establish a new ambitious initiative: Oncode-PACT. The goal? To innovate the oncology drug development infrastructure  to drive faster and more cost-effective development of new effective cancer drugs. Oncode Institute was one of the initiators of this consortium and we are excited to be part of it. It is the logical next step to enlarge our impact on patient lives.

We are excited for what’s coming our way. More great science, more collaborations and more impactful valorisation. And above all, with more opportunities to meet face-to-face.  
 
We hope to see you soon! 

The Oncode Managing Board